Bacterin Adds to Board

Belgrade, Mont.-based Bacterin International Holdings Inc., which makes bone graft material and coatings for medical applications, has added David Goodman. M.D., MSE to its board of directors. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and executive vice president of business development for Masimo. The board unanimously elected Goodman to fill the vacancy created by Mitchell Godfrey’s recent resignation.

“David is joining the board with a distinguished career in improving health through the development and integration of innovative technologies into clinical practice,” said President/CEO Dan Goldberger. “His experience with companies in all stages of development will add an extremely well rounded perspective to the board.”

Goodman currently serves as co-founder and chief medical officer of FirstVitals Health & Wellness, a technology-enabled service company focused on preventing complications such as foot ulcers and lower extremity amputations in people with diabetes. He also serves on the board of NEUROMetrix and was previously on the board of Sound Surgical prior to its acquisition by Solta Medical. Throughout his career, Goodman has founded three healthcare companies and holds 18 issued and 4 pending U.S. patents.

Goodman holds a B.A.S. in applied science and bioengineering, an M.S.E. in bioengineering from the University of Pennsylvania, and an M.D. cum laude from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology.